SCHEMBL2067935

SCHEMBL2067935

CCOC(=O)c1nc2cccnn2c1S(N)(=O)=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 4/20 0.67
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 2/20 0.41
PDE4B Q07343 4/20 0.40
PDE4D Q08499 4/20 0.40
CA1 P00915 4/20 0.40
CA2 P00918 4/20 0.40
PDE4C Q08493 3/20 0.40
CA4 P22748 3/20 0.40
CA9 Q16790 3/20 0.40
KDM4E B2RXH2 1/20 0.39
BRD4 O60885 1/20 0.39
MAPK1 P28482 1/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NTRK1 P04629 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2066273 0.88 PDE4A (0.67) PDE4APTGS1PTGS2NPC1RAB9A
SCHEMBL17492384 0.81 PDE4A (0.76) PDE4APTGS1PTGS2NPC1RAB9A
SCHEMBL17492366 0.81 PDE4A (1.00) PDE4APTGS1PTGS2NPC1RAB9A
SCHEMBL2065529 0.80 PDE4A (0.43) PDE4APDE4BPDE4DPDE4C
SCHEMBL9520695 0.79 PTGS1 (0.60) PDE4APTGS1PTGS2RAB9AKDM4E
SCHEMBL2068560 0.78 PDE4A (0.43) PDE4APTGS1PTGS2NPC1RAB9A
SCHEMBL2066471 0.76 PDE4A (0.40) PDE4APTGS2PDE4BPDE4DCA1
SCHEMBL31312781 0.76 PDE4A (0.67) PDE4APTGS1PTGS2PDE4BPDE4D
SCHEMBL2066954 0.75 PDE4A (0.40) PDE4APTGS1PTGS2PDE4BPDE4D
SCHEMBL2066982 0.74 PDE4A (0.39) PDE4APTGS1PTGS2PDE4BPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148524-B2 Process for producing sulfonyl chloride compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-03 US disclosed
EP-1932846-B1 METHOD FOR PRODUCING SULFONYL CHLORIDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2010-10-27 EP disclosed
US-20090247748-A1 PROCESS FOR PRODUCING SULFONYL CHLORIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-10-01 US disclosed
EP-1932846-A1 METHOD FOR PRODUCING SULFONYL CHLORIDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247748-A1 PROCESS FOR PRODUCING SULFONYL CHLORIDE COMPOUND SALL4, CLCN2, CLIC1 PDE4A 4317/4885PTGS1 4259/4885PTGS2 4202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.